Education and Training

Medical School

MD - SUNY Upstate Medical University, Syracuse, NY

Internship

Medicine - Children’s Hospital of Philadelphia, Philadelphia, PA

Residency

Medicine - Children’s Hospital of Philadelphia, Philadelphia, PA

Fellowship

Pediatric Bone Marrow Transplant & Immunotherapy - Children’s Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology/Oncology - Children’s Hospital of Philadelphia, Philadelphia, PA
Pediatric Hospital Epidemiology and Outcomes Research Training Program - Children’s Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatrics

Graduate Degree

MSCE - University of Pennsylvania, Philadelphia, PA
MA in Biological Sciences - Hunter College of the City of New York, New York, NY

Titles and Academic Titles

Attending Physician

Instructor, Perelman School of Medicine at the University of Pennsylvania

Departments and Services

Publications

Papers

2019

Getz K, Sung L, Ky B, Gerbing R, Leger K, Leahy AB, Sack L, Woods W, Alonzo T, Gamis A, Aplenc R.: Occurrence of Treatment-Related Cardiotoxicity and its Impact on Outcomes among Children Treated on the AAML0531 Clinical Trial: A Report from the Children's Oncology Group. JCO  Page: 12-21, January 2019.

2017

Hill D, Leahy AB, Sciasci J, O’Neill S, Reilly A, Balamuth N, Seeholzer S, Spergel J, Brown-Whitehorn T. Medication contaminants as a potential cause of anaphylaxis to vincristine. Pediatr Blood Cancer. 2017 Aug 22. Epub ahead of print.

2016

Basch E, Deal A, Kris MG, Scher H, Hudis C, Sabbatini P, Rogak L, Bennett A, Dueck A, Atkinson T, Chou J, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan J, Schrag D. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol. 2016 Feb 20; 34(6):557-65.

2014

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep 29;106(9)

2013

Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, et al. Feasibility of Long-Term Patient Self- Reporting of Toxicities From Home via the Internet During Routine Chemotherapy. J Clin Oncol. 2013 Jul 10;31(20):2580-5.

2009

Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S, Culkin A, Kris M, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. Journal of the National Cancer Institute. 2009 Dec 101(23): 1624-1632.

2007

Basch E, Iasonos A, Barz A, Culkin A, Kris M, Artz D, Fearn P, Speakman J, Scher H, McCabe M, Schrag D. Online symptom self-reporting by lung cancer patients using the Common Terminology Criteria for Adverse Events (CTCAE). Journal of Clinical Oncology. 2007 Dec 25(34): 5374-80.

Basch E, Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher H, McCabe M, Schrag D. Evaluation of an online platform for cancer patient selfreporting of chemotherapy toxicities. Journal of the American Medical Informatics Association. 2007 May 14(3): 264-268.

2006

Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology. 2006 Nov 7(11): 883-4.

2004

Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady M, Roy P, Song Y, Canchola R, Barz A, Bolognia J, Eng S, Elahi A, Begg CB. Estimating the relative risk of developingmelanoma in INK4A carriers. European Journal of Cancer Prevention. 2004 Feb 13(1): 65- 70.

2001

Orlow I, Roy P, Barz A, Canchola R, Song Y, Berwick M. Validation of denaturing high performance liquid chromatograph as a rapid detection method for the identification of human INK4A gene mutations. Journal of Molecular Diagnostics. 2001 Nov 3(4): 158-63.

Abstracts

2017

Getz K, Sung L, Ky B, Gerbing R, Leger K, Leahy AB, Sack L, Woods W, Alonzo T, Gamis A, Aplenc R. Incidence and Predictors of Anthracycline Cardiotoxicity among Children Treated on the AAML0531 Clinical Trial: A Report from the Children’s Oncology Group. Submitted to ASH Annual Meeting 2017.

Posters and Presentations

2018

Leahy AB, Helton G, Scholes D, Jurgielewicz A, Reeve BB, Schwartz L, Aplenc R, Basch E: Pediatric Patient-Reported Symptom Tracking in Oncology (Pedi-PReSTO): A Feasibility Study. Poster presentation, American Society of Hematology Annual Meeting  2018.

Leahy AB, Elgarten C, Li Y, Huang Y-S, Fisher BT, Delp D, Aplenc R, Getz K. : Evaluation of Hospital Admission Patterns in Children Receiving Treatment for Acute Lymphoblastic Leukemia: what does a typical leukemia experience look like? Poster presentation, American Society of Hematology Annual Meeting 2018.

Leahy AB, Scholes D, Helton G, Reeve BB, Schwartz L, Aplenc R, Basch E. : Symptom monitoring using patient-reported outcome (PRO) instruments in pediatric oncology patients hospitalized for chemotherapy: A feasibility study. Oral presentation, International Society for Quality of Life (ISOQOL) Annual Meeting October 2018.

Invited Lectures

2018

Leahy AB. "Clinical benefits of integrating patient-reported outcome measures into routine oncology practice for symptom monitoring."  Annual Meeting of the German, Austrian, and Swiss Associations for Hematology and Medical Oncology. Vienna, Austria. Aug, 2018.

Leahy AB. "Pedi'PReSTO: Patient-Reported Symptom Tracking in Oncology at CHOP."  St. Jude Webinar. Apr, 2018.

Leahy AB. "Pediatric Patient-Reported Symptom Tracking in Oncology at the Children's Hospital of Philadelphia." Pediatric PRO Research Network Group Meeting Webinar. Feb, 2018.

2017

Leahy AB. "Pedi-PReSTO: Pediatric Patient-Reported Symptom Tracking in Oncology."  Group Cancer Control Webinar. Nov, 2017.

Leahy AB. "Gabapentin as an antiemetic." - Children's Oncology Group Cancer Control Webinar. Nov, 2017.

Leahy AB. “Gabapentin as an antiemetic” – Children’s Oncology Group Cancer Control Webinar. September 2017.

Awards and Honors

2017-2018, American Society of Hematology Clinical Research Training Program Fellow
2017-present, Recipient of NIH Loan Repayment Program in Pediatric Research
2017-2018, American Society of Hematology Clinical Research Training Program Fellow
2011, Dracker Family Scholarship
2011, Jack J. Schneider Scholarship
2011, Commendation, outstanding performance in clinical years, SUNY Upstate College of Medicine
2011, Gold Humanism Honor Society
2011, Alpha Omega Alpha

Editorial and Academic Positions

Editorial Positions

Reviewer

2018-present, Clinical Trials
2018-present, JAMA
2018-present, Pediatric Hematology and Oncology
2017-present, Supportive Care in Cancer
2017-present, Journal of Clinical Oncology
2017-present, Cancer

Academic and Institutional Committees

2016-present, Lead, Quality Improvement Project
2016-2018, Fellow Liaison, Pediatric Hematology/Oncology Fellowship

Leadership and Memberships

Memberships in Professional Organizations

International

2017-present, International Society for Quality of Life Research

National

2017-present, American College of Epidemiology
2017-present, American Society of Hematology
2016-present, American Society of Pediatric Hematology and Oncology
2015-present, Children’s Oncology Group
2014-present, American Society of Clinical Oncology